GRIA2 and Alzheimer disease: A recent compilation of 38 proteomic studies of AD reported a total of 12 studies where GluA2 protein expression was reduced in the frontal, entorhinal, and parahippocampal cortex, as well as the hippocampus and precuneus brain regions of AD brains [29].